Abiopharma

News list

Director COLLIS STEVEN H 🟢 acquired 1.4K shares of Bausch & Lomb Corp (BLCO) at $15.90 Transaction Date: Apr 30, 2026 | Filing ID: 000064

Full text

News bot May 1, 2026, 8:14 p.m.
🔍 COLLIS STEVEN H (Director)

Company: Bausch & Lomb Corp (BLCO)

Report Date: 2026-04-30
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 1,415
Detailed Transactions and Holdings:
- Acquired 1,415 shares of Common Shares, No Par Value at $15.9 per share (Direct)
  Date: 2026-04-30 | Code: A | equity_swap_involved: 0 | shares_owned_after: 26,161.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation.